IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

BVF Inc

Portfolio Profile

CIK: 0001056807 | San Francisco, CA

Investment Profile

Style

Core

Turnover

Medium

Orientation

Concentrated trader
$3.9B
AUM
44
Positions
65.59%
Top 10 Conc.
92.49%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Revolution Medicines Inc(RVMD)2,965,160$555.3M14.20%
2Kymera Therapeutics Inc(KYMR)3,872,052$444.0M11.35%
3Xoma Royalty Corporation(XOMA)7,593,303$322.7M8.25%
4Moonlake Immunotherapeutics(MLTX)16,001,284$311.5M7.97%
5GH Research PLC(GHRS)8,650,158$232.5M5.95%

Sector Allocation

Latest filing, equity positions only

Healthcare93.5% · $3.7B
Unclassified6.5% · $254.2M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare96.05%93.5%-2.55%
Unclassified3.95%6.5%+2.55%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$3.7B | 69 pos.
$4.0B | 70 pos.
$3.6B | 62 pos.
$3.6B | 60 pos.
$3.4B | 55 pos.
$3.0B | 53 pos.
6
Structure Therapeutics Inc(GPCR)
3,366,823
$180.7M
4.62%
7Nektar Therapeutics(NKTR)2,391,075$166.9M4.27%
8Mirum Pharmaceuticals Inc(MIRM)1,056,027$123.6M3.16%
9Xencor Inc(XNCR)7,133,720$114.9M2.94%
10Alkermes PLC(ALKS)2,154,704$112.9M2.89%
Cap SizePrev %Curr %Change
Small Cap44.25%43.9%-0.35%
Mid Cap37.7%29.65%-8.05%
Large Cap8.85%14.2%+5.35%
Unclassified3.95%6.5%+2.55%
Micro Cap5.25%5.75%+0.5%
$2.5B | 51 pos.
$2.8B | 44 pos.
$2.5B | 46 pos.
$3.0B | 41 pos.
$3.1B | 41 pos.
$3.9B | 44 pos.
Q3
23
Q4
23
Q1
24
Q2
24
Q3
24
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

7
New
4
Closed
6
Increased
8
Decreased
23
Unchanged